Quick Answer
CNBX Pharmaceuticals Inc. reported Total Assets of $18.4 thousand for fiscal year 2025.
CNBX Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $18.4K | -41.3% |
| 2024 | $31.4K | -93.7% |
| 2023 | $499.0K | -38.5% |
| 2022 | $811.2K | -73.7% |
| 2021 | $3.08M | +38.7% |
| 2020 | $2.22M | -85.4% |
| 2019 | $15.18M | +376.7% |
| 2018 | $3.18M | -12.4% |
| 2017 | $3.64M | +15238.8% |
| 2016 | $23.7K | -17.4% |
| 2015 | $28.7K | -74.9% |
| 2014 | $114.2K | +57.0% |
| 2013 | $72.8K | -23.4% |
| 2010 | $95.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $11.2K | -50.0% | -39.5% |
| August 31, 2025 | $18.4K | -41.3% | -1.0% |
| May 31, 2025 | $18.6K | -76.7% | -63.3% |
| February 28, 2025 | $50.7K | -69.1% | +127.1% |
| November 30, 2024 | $22.3K | -94.2% | -28.9% |
| August 31, 2024 | $31.4K | -93.7% | -60.8% |
| May 31, 2024 | $80.0K | -87.9% | -51.2% |
| February 29, 2024 | $163.9K | -64.5% | -57.7% |
- CNBX Pharmaceuticals Inc. showed a decrease of -41.3% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, CNBX Pharmaceuticals Inc.’s total assets has declined by 80.6% (from $95.0 thousand to $18.4 thousand).
- The most recent figure is from CNBX Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: